Functional implications of the recently described fatty acid conjugation of budesonide (BUD) (Tunek, A., K. Sjödin, and G. Hallström, Drug Metabol. Dispos. 1997;25:1311-1317 Miller-Larson, A., E. Hjertberg, H. Mattsson, M. Dahlbäck, A. Tunek, and R. Brattsand, Am. J. Respir. Crit. Care Med. 1997;155:A353 [Abstr.]) were studied in a rat cell line, Rat1, transfected with the activation protein-1 (AP-1)-controlled regulatory element (TRE) driving the reporter gene ␤ -galactosidase. TRE is downregulated by glucocorticosteroids (GCS) through interaction with the AP-1 complex. BUD was compared to fluticasone propionate (FP), a potent glucocorticosteroid that does not form fatty acid conjugates. The kinetics and metabolism of the GCS were studied after incubation of either 3 H-BUD or 3 H-FP with transfected Rat1 cells. Up to 20% of added BUD was taken up into the cells over 24 h. The great majority of the intracellular radioactivity (80-90%) consisted of lipophilic BUD conjugates. After removing extracellular 3 H-GCS, the outflow of radioactivity was studied. Only free BUD and not fatty acid conjugates was detected extracellularly, suggesting that hydrolysis of the conjugates was required to release BUD from the cell. During 165 min, less BUD (about 65% of totally incorporated) was released than FP (more than 90%). In the functional studies, FP was about six times more potent than BUD in downregulating TRE after 24 h continuous exposure. However, after a 6-h pulse of GCS, the effect of BUD persisted unchanged 18 h later, whereas FP had almost lost its efficacy ( P Ͻ 0.05 between the drugs). In addition, the reversible conjugation process of BUD resulted in transferable GCS effects. Medium containing released BUD from previously loaded cells mediated nearly the same downregulatory effect after addition to naive cells as did continuous treatment. No such transferable effect was seen for FP. In conclusion, the reversible fatty acid conjugation of BUD resulted in prolonged cellular retention and anti-inflammatory activity after pulse exposure in this in vitro system. This fatty acid conjugation mechanism appears to add to the beneficial pharmacologic profile of BUD. Wieslander, E., E.-L. Delander, L. Järkelid, E. Hjertberg, A. Tunek, and R. Brattsand. 1998. Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line in vitro . Am. J. Respir. Cell Mol. Biol. 19:477-484.
Glucocorticosteroids (GCS) developed for inhalation, such as budesonide (BUD) and fluticasone propionate (FP), exhibit better airway selectivity than earlier generations of steroids developed for systemic use, such as hydrocortisone (HC), prednisolone, and dexamethasone (1) . A key chemical feature mediating this selectivity is lipophilicity. Optimal lipophilicity obtained by appropriate substitutions will enhance both receptor affinity (2) and hepatic first-pass inactivation (1) . In addition, optimal lipophilicity maximizes dwell time within tissue, which seems to be another key component for the desired airway selectivity of inhaled GCS.
The relationship between lipophilicity and airway potency has hitherto been evaluated in terms of the intact steroids (2, 3) because there has been little evidence of local metabolism. The recently discovered, reversible fatty acid conjugation of BUD adds novel concepts to this discussion. GCS esterified at the C-21 position, such as in the fatty acid conjugates of BUD (4) , have been shown to have very low or no affinity to the GCS receptor (1, 2) . Thus, these conjugates are considered inactive . BUD can be conjugated to fatty acids within many cell types and in that way can be stored in an inactive but recoverable form. The conjugated BUD can be hydrolyzed by intracellular lipases, releasing free and pharmacologically active BUD (4, 5) . Of four GCS (BUD, beclomethasone propionate [BDP] , FP, and HC) studied in human lung tissue in vitro , only BUD undergoes a substantial fatty acid conjugation (4, 5) . In a rat tracheal model, a more protracted tissue binding has been reported for BUD than for the other three GCS, suggesting that conjugated BUD might also serve as a depot in the tissue (5, 6) in vivo .
Conjugation of steroids to nonpolar compounds in vivo and in vitro has been described previously (7, 8) . The lipophilic compounds have been characterized as fatty acid esters (8) and shown to occur for a number of different steroids, including endogenous GCS and estrogens (9, 10) . To our knowledge, however, formation of fatty acid esters of a synthetic GCS has not been reported previously.
The aim of the present study was to investigate the functional implications of the fatty acid conjugation of BUD in a well-defined cellular system in vitro in which concentration and exposure time could be adequately controlled. In this system, pulse exposure versus continuous exposure to the GCS was compared. This has clinical relevance because GCS are inhaled one to four times daily and a changed activity profile after pulse exposure may affect both therapeutic and adverse effects. BUD was compared with FP, which has higher receptor affinity (2, 11) than BUD but does not undergo fatty acid conjugation.
As a readout for functional GCS activity, Rat1 cells transfected with the regulatory element TRE (AP-1 controlled regulatory element) coupled to the reporter gene ␤ -galactosidase was used. Steroids inhibit TRE by binding of the GCS-receptor (GR) complex to the transcription factor AP-1 (activation protein-1), which otherwise activates transcription via TRE (12) . Activation of AP-1 and its subsequent binding to regulatory elements such as TRE is important in mediating the pro-inflammatory effects of many cytokines, growth factors, and proteases (12) . Inhibiting AP-1/TRE activation is one important mechanism behind the therapeutic efficacy of GCS in asthma (13) .
Materials and Methods

Reagents
O -nitrophenol-␤ -D -galactopyranoside (ONPG) was obtained from Sigma (St. Louis, MO). Cell culture media and fetal calf serum (FCS) were purchased from GIBCO BRL (Paisley, UK). BUD, FP, and BUD-oleate were obtained from Astra Draco AB (Lund, Sweden). All other chemicals were of analytical grade.
Radiochemicals
H-BUD and
3 H-FP (radiochemical purity Ͼ 97%) were obtained from Radiochemical Center (Amersham, Little Chalfont, UK) or Astra Draco AB. The radiochemical concentration was 1.1-3.8 mCi/ml for BUD (specific radioactivity, 17-37 Ci/mmol), and 1.3-2.0 mCi/ml for FP (specific radioactivity, 5.4-33 Ci/mmol). The 3 H-GCS were stored in stock solutions in ethanol at Ϫ 20 Њ C at a concentration of 10 Ϫ 4 to 10 Ϫ 5 mol/liter.
Cell Culture Materials
All cell culture plastics were obtained from Costar (Badhoevedorp, The Netherlands), except 50-ml sterile tubes from Falcon (Labora, Stockholm, Sweden) and microtiter plates from Nunc (Roskilde, Denmark).
Cell Culture
The rat fibroblast cell line, Rat1 (14) , was initially obtained from Dr. Å. Oldberg, University of Lund (Lund, Sweden). The Astra Draco-derived Rat1 TRElacZ transfectant was grown in Dulbecco's modified Eagle's medium supplemented with 10% FCS, glutamine (4 mmol/liter), penicillin (50 U/ml), streptomycin (50 IU/ml), and 1% nonessential amino acids (GIBCO). Cells were cultured at 37 Њ C and 5% CO 2 , and passaged once weekly; experiments were performed on cells within 15 passages. Transrepression (12) mediated by GR/AP-1 interactions with TRE was studied after GCS treatment.
Reporter Gene Assay
The activity of TRE in the transfected Rat1 cells was determined by assaying the reporter gene lac Z ( ␤ -galactosidase). Enzyme activity was determined by a spectrophotometric assay performed in microtiter plates. Cells were lysed with 50 l 0.5% (or 0.1% when protein was determined simultaneously) Triton X-100 followed by the addition of 40 l of the reaction mixture ( 
Pharmacokinetic Studies
Uptake and time course of formation of lipophilic conjugates. Transfected Rat1 cells were seeded in 10-cm petri dishes and allowed to grow to about 90% confluency. Medium containing 3 H-BUD at a concentration of 3 ϫ 10 Ϫ 8 mol/liter (diluted from the ethanol stock solution, taking care not to exceed 0.1% ethanol in the final solution) was added. After incubation for 30 min, 6 h, or 24 h at 37 Њ C in 5% CO 2 , cells were rapidly washed five times with medium and scraped from the dish in a small volume of medium. The cell suspension was then centrifuged at 1,000 rpm and 4 Њ C for 10 min and the medium carefully removed. Results are given as percentage of total amount of radioactivity added to the culture, mean of three dishes (standard deviation, SD). In a similar experiment, pellets were extracted in 2 ml of ethanol (99.9%) overnight at room temperature and the ethanol phase subjected to high-pressure liquid chromatography (HPLC) in liquid chromatography-system 1 as described by Tunek and associates (4) . Temporal study of the reversibility of conjugation. Transfected Rat1 cells were incubated with medium containing 3 ϫ 10 Ϫ 8 mol/liter 3 H-BUD or 3 H-FP for 2 h. After rapid washing three times, GCS-free medium was added to the cells. During further incubation for 165 min, 2 ϫ 100 l was taken for analysis of radioactivity at different time points. The samples were replaced with fresh medium. At the end of the experiment, cells were washed and harvested as above for analysis of radioactivity in the ethanol extracts. Some medium samples were fractionated by HPLC in LC-system 3 (4) to study the balance between free and conjugated GCS.
Estimation of GCS concentrations in cells and medium after pulse administration. Experiments were performed as described below (duration or conditioned-medium experiments), except that 3 H-BUD and 3 H-FP at 10 Ϫ 7 mol/liter were used. When mimicking the pulse-duration studies, the cells were moved to new flasks instead of microplates to facilitate recovery of medium and cells. Samples (0.5 ml) from each incubation step were taken and added to scintillation vials. After removal of the last medium from the cells, they were scraped from the flasks and centrifuged, and radioactivity was determined in the pellet using Ultima Gold as scintillation fluid. Results were calculated as percent radioactivity recovered from the initial amount added.
Pharmacodynamic Studies
Continuous exposure: dose-response studies. Transfected Rat1 cells were grown in microplates to about 90% confluency. Medium was changed to medium containing GCS (either BUD, BUD-oleate, or FP) at concentrations ranging from 10 Ϫ 12 to 10 Ϫ 6 mol/liter. Cultures were further incubated for 24 h, followed by determination of ␤ -galactosidase activity in the cells.
Pulse exposure: comparison of activity of BUD and FP after a 6-h pulse of GCS. Transfected Rat1 cells were cultured in flasks with BUD (10 Ϫ 7 mol/liter) or FP (10 Ϫ 7 or 2 ϫ 10 Ϫ 8 mol/liter) for 6 h. Cells were thereafter washed repeatedly by incubating them five times for 5 min with fresh medium. This washing procedure was included in order to remove as much free and rapidly extractable (presumably nonconjugated) GCS as possible. Thus, when washed five times, 85 to 90% of BUD (compared with rapid washing) was retained in the cells but only 10 to 30% of FP ( see also Because of the much stronger plastic adhesion of FP compared with BUD (data in the files of Astra Draco), cells had to be moved to microplates after the initial GCS pulse plus washing, using gentle trypsinization. After an additional 18 h, TRE and protein levels were determined in transferred cells. If seeded on a monolayer of nontransfected Rat1 cells as a "feeder" layer, trypsinization did not seem to affect the downregulation, because similar downregulation after GCS was detected whether the cells were moved or not (data not shown). Control cells were trypsinized and seeded in microplates simultaneously with addition of the GCS and further incubated for 18 h.
Protein was determined essentially according to Bradford (15) employing a kit (BioRad Laboratories, Hercules, CA). Protein was determined in order to correct for potential interference from GCS-mediated effects on adhesion of cells to the new wells. Downregulation of TRE was calculated by relating the activity of ␤ -galactosidase to the amount of protein.
Conditioned medium: release of transferable activity into conditioned medium. Transfected Rat1 cells were incubated with GCS-containing medium (10 Ϫ 7 mol/liter BUD and 10 Ϫ 7 or 2 ϫ 10 Ϫ 8 mol/liter FP) for 3 h before changing to GCS-free medium and culture for an additional hour. Thereafter, cells were washed intensively five times with 5 min incubation, and the last wash medium was collected. After the washings (performed to remove free, nonconjugated GCS), cells were transferred to new flasks by gentle trypsinization as described above. No feeder layer was used. GCS-free medium was again added and the cultures continued for an additional 3 h to allow release of reversibly conjugated GCS. Thereafter, the medium conditioned with the released GCS was collected. The last wash and this 3-h conditioned medium (CM) were centrifuged at 4 Њ C and 1,000 rpm for 10 min to remove loose cells, and added to new cultures of transfected Rat1 cells grown in microplates. The plates were incubated at 37 Њ C overnight before determination of the downregulation of TRE mediated by released GCS in the CM. Control cells were treated in the same way except that all washes and subsequent media contained the GCS at adequate concentration.
Statistics
For the dose-response studies, parallel sigmoidal curves were fitted to data using nonlinear regression. The relative dose potency was estimated from the horizontal distance of the curves and 95% confidence limits were constructed. In the BUD-FP duration and CM studies, data were analyzed using analysis of variance followed by sequential pairwise comparisons. In the duration studies, this was performed in two ways. In Method 1, comparison between the downregulation of BUD and FP after the 6-h pulse was performed. In Method 2, comparison between the downregulation after the 6-h pulse and the downregulation after continuous incubation (control) was made for each GCS.
Results
Pharmacokinetic Studies
Uptake of BUD and time course of formation of lipophilic conjugates. Incorporation of 3 H-BUD into transfected Rat1 cells increased during the investigated period; from a mean of 3.3% (SD 0.24) of totally added radioactivity at 30 min to 15.6% (SD 1.4) at 6 h to 21.3% (SD 1.5) at 24 h. Thus, after 24 h about 20% of the initially added radioactivity had been taken up by the cells. The proportion of the total amount of intracellular radioactivity present as lipophilic conjugates remained at 80 to 90% during the whole time period studied (Figure 1 ). The main conjugate peak contains BUD-oleate and the smaller peak contains BUD-palmitoleate, but both peaks are probably mixtures of more than one fatty acid ester.
Release of GCS-derived radioactivity from preloaded Rat1 cells. In another experiment, cells were loaded with 3 H-GCS for 2 h. About 20% of total added radioactivity from either BUD or FP was taken up. After washing to remove nonconjugated GCS, 13.3% of BUD and 5.8% of FP remained in the cells. The release of remaining intracellular GCS was followed during 165 min (Figure 2 ). For FP, a steady state in the medium was reached after only 25 min, whereas the release of BUD was markedly slower, with total extracellular levels constantly increasing. Presumably, the rate-limiting step for release of BUD was hydrolysis of the fatty acid conjugates. Almost 25 times less FP (0.2%) than BUD (5.0%) remained in the cells at the end of the experiment. More than 90% of the FP-related radioactivity in the cells at the beginning of the release period was released over 165 min compared with about 65% of BUDrelated radioactivity. HPLC analysis of the BUD medium at 15, 55, and 165 min in a similar experiment revealed that all of the extracellular radioactivity represented intact BUD; no lipophilic conjugates were found in the medium ( Figure  3 ). Note that in HPLC system 3, the conjugates have longer retention time than in system 1 (4) (and are thus not recorded on this part of the tracing). In a separate experiment, the HPLC profiles of cells treated with 3 H-BUD or 3 H-FP confirmed that no lipophilic conjugates were formed with FP in the transfected Rat1 cells (data not shown).
Disposition of the GCS during pulse-duration and conditioned-medium experiments.
The disposition of total radioactivity during experiments comparing the duration of pharmacologic activity of BUD and FP is shown in Table 1 (Duration Experiments section). After the 6-h pulse incubation and washes, approximately 13% of totally added 3 H-BUD radioactivity was estimated to be retained in the cells. The subsequent movements and further incubation over 18 h reduced that proportion to approximately 5% (i.e., more than one-third of the amount after the last wash was still retained within the cells). For FP, the amount in the cells at the end of the 6-h pulse period (after the last wash) was estimated to be approximately 0.7%, presumably due to larger losses during washes. Furthermore, only 0.1% remained in the cells at the end of the 18-h incubation. Thus, at the end, the amount of FP in the cells was 50 times lower than that of BUD (free and conjugated).
A similar kinetic difference between the substances was seen in the CM experiments (Table 1 , Conditioned-Medium Experiments section). The generally lower level of GCS in medium and cells reflects the shorter GCS pulse (3 h). The proportion of radioactivity recovered in the last wash was similar for both GCS. However, during production of the CM over the next 3 h, more than 10-fold greater radioactivity was released from the BUD-treated cells (4.1%) than from the FP-treated cells (0.4%). While for BUD this release represented a more than 10-fold increment over what was found in the last wash, there was no difference for the FP-treated cells. In these experiments, as in the pulse experiments, 50 times more BUD than FP was retained intracellularly at the end of the experiment.
Pharmacodynamic Studies
Continuous exposure: dose-response. The relative potencies in downregulating TRE in transfected Rat1 cells are shown in Table 2 and exemplified in Figure 4 . By using a sigmoidal model to describe the dose-response curves, FP was estimated to be about six times (95% confidence limits: 3.4-11.8, n ϭ 8) more potent than BUD. On the basis of that ratio, in the subsequent studies BUD was compared with two concentrations of FP, where the lower concentration of 2 ϫ 10 Ϫ8 mol/liter was considered roughly equipotent with 10 Ϫ7 mol/liter BUD (as determined during continuous exposure). In addition, BUD was estimated to be about 150 times more potent (confidence limits: 37-671, n ϭ 3) compared with extracellularly added BUDoleate.
Pulse exposure: effect after a 6-h GCS pulse and subsequent move of the cells to new microplates. Cells were treated with a 6-h pulse of BUD or FP, washed intensively, and moved to new microplates containing a feeder layer of nontransfected cells (to facilitate adherence). The cells had to be moved to avoid the strong plastic adsorption of FP mentioned previously, which strongly interfered with the experimental outcome. The remaining efficacy 18 h after the GCS pulse is shown in Figure 5 (note that effects are related to the amount of protein in the cultures to account for potential differences in adhesion of the moved cells). The mean level of downregulation in the control cultures with 24-h continuous exposure was around 60%. After a 6-h pulse, BUD (10 Ϫ7 mol/liter) caused 54% downregulation, whereas FP (10 Ϫ7 and 2 ϫ 10 Ϫ8 mol/liter) downregulated TRE by only 28 and Ϫ11%, respectively (P Ͻ 0.05 and P Ͻ 0.001, compared with BUD). The BUD response to a 6-h pulse did not differ significantly from the corresponding values with continuous incubation, whereas this was clearly the case for the equipotent FP concentration (2 ϫ 10 Ϫ8 mol/liter) and even for the higher FP concentration, 10 Ϫ7 mol/liter. Thus, with pulse exposure FP downregulated TRE significantly less than in the continuously exposed controls (P Ͻ 0.001 for both concentrations).
Production of conditioned medium containing GCS activity. Cells were pulsed with BUD and FP for 3 h, intensively washed, and subsequently moved to new flasks, where released GCS was collected in fresh medium (defined as CM after the 3 h incubation) over 3 h. The effect of CM from cells pretreated with BUD (10 Ϫ7 mol/liter) or FP (10 Ϫ7 mol/liter or 2 ϫ 10 Ϫ8 mol/liter) on naive cells is shown in Figure 6 . At t ϭ 0 (from "last wash"), no downregulatory activity was mediated by BUD-treated cells. However, the "last wash" from FP-treated cells mediated a substantial downregulatory activity (around 23%). This effect was shown to be the result of FP strongly adhering to the plastics of the initial wells, indicating the necessity of moving the cells to new flasks. In fact, a similar effect of CM was obtained from incubations with FP-containing medium (10 Ϫ7 mol/liter) in flasks with or without transfected Rat1 cells. Moving the cells to new flasks prevented this interference (data not shown).
CM collected over the 3-h incubation (t ϭ 3) with BUD-pretreated cells induced a substantial downregulation (around 33%) when added to naive transfected Rat1 cells. Analysis of variance with pairwise comparisons of the drugs revealed that the BUD-pretreated cells provoked a significantly larger increase in response (from t ϭ 0 to t ϭ 3) after the 3-h release period compared with FPpretreated cells (P Ͻ 0.001). In fact, downregulation mediated by the 3-h CM from BUD-treated cells was only slightly less than after continuous incubation (33% versus 42%). The 3-h CM from FP-treated cells induced only minor effects.
Discussion
Asthma is a chronic inflammatory disease of the airways, and inhaled GCS are known to be the first choice of therapy for its long-term treatment. Key properties of these GCS are a combination of high receptor affinity, a high hepatic first-pass inactivation, and a prolonged binding to target tissue (1, 11) . These desired properties are improved by a high lipophilicity (2, 16) . However, the optimal lipophilicity is not known, and none of the current GCS have been designed for and primarily selected in airway models. Moreover, the models that have been used to describe the properties of inhaled GCS, such as receptor affinity (2, 3, 11, 17) and functional potency in target or non-target cells (18) (19) (20) , have been in vitro models. In these models, FP and BDP (for the latter compound partly through its primary hydrolysis product beclomethasone monopropionate) exhibit the highest potency, and they are also the most lipophilic steroids. These in vitro studies were based on a continuous incubation of test GCS, whereas, in the clinical situation, inhalation therapy is administered as local pulses, followed by GCS drainage from target via blood circulation. The importance of a varying extent of prolonged tissue binding will presumably be poorly detected in experiments based on continuous GCS incubation in vitro.
The aim of this study was to compare coupled kinetics and dynamics (especially regarding duration) of the two potent GCS, BUD and FP. The latter has higher lipophilicity, twice the receptor affinity, and sometimes an even higher functional potency compared with BUD in assays in vitro (2, 11, 19) , but lacks the free hydroxyl in the 17␤ side-chain required for formation of fatty acid conjugates. Moreover, no fatty acid conjugate formation by FP has been seen in human or rat tissues as well as in the transfected Rat1 cell line. In inhalation therapy in clinical asthma, the potency difference between BUD and FP has been reported to be 2-fold (21; based on meta-analysis) or lacking (22) . Furthermore, in a series of controlled trials BUD demonstrated efficacy even on a once-daily regimen (23, 24) . This suggests that the earlier in vitro tests may not adequately mimic the clinical efficacy. Thus, one aim was to design in vitro models where especially duration comparisons could be performed better and, for BUD, to relate results after both continuous and pulse exposure to the fatty acid conjugation. Transfected Rat1 cells were shown to conjugate and deconjugate BUD in a similar manner to the reversible conjugation in airways recently described (4, 5) and were thus selected as a suitable cell system.
Kinetics of Fatty Acid Conjugation in Rat1 Cells
The uptake studies revealed that the intracellular formation of fatty acid conjugates of BUD is a rapid process. After only 30 min of incubation, the great majority of intracellular BUD existed in the conjugated form. In vitro studies in microsomal systems show that acetyl coenzyme A and adenosine triphosphate are required for BUD conjugation (4) and that the conjugation is partly blocked by inhibitors of acyl coenzyme A:cholesterol acyltransferase inhibitors (data not shown). Together, these data suggest that BUD conjugation might resemble the metabolic routes of cholesterol or endogenous steroids, such as estrogens (25) . However, the exact enzymatic pathway of the conjugation process remains to be elucidated.
The conjugation was reversible; that is, when the medium was replaced with medium without BUD, the nonconjugated steroid but not the lipophilic conjugates was released from the cells. The reversibility of the fatty acid conjugation of BUD seems to be dependent on the action of lipases as reported recently (4) . In analogy with already described fatty acid conjugates of estrogens (26), a potential lipase candidate could be hormone-sensitive lipase (27) . Further studies of these mechanisms are ongoing in our laboratory.
Presumably due to the reversible conjugation reaction, BUD was more efficiently retained intracellularly than FP, which cannot be conjugated. Thus, about 30 to 50 times more BUD than FP was retained in the cells after prolonged incubation in GCS-free medium. FP was also more easily removed from cells by extensive washings, in spite of its higher lipophilicity (FP being eight times more lipophilic than BUD [5] ). However, the lipophilicity of BUDoleate was shown to be 500 times higher than that of FP (5; data in the files of Astra Draco). A concordant retention of BUD was also seen in vivo and in studies employing rat trachea ex vivo (5, 6) , showing that pulse exposure in cell cultures can mimic in vivo kinetics with its continuous blood drainage.
Aspects of Fatty Acid Conjugation Related to Functional GCS Activity
The uptake studies also show that the proportion of conjugate formation seems to be constant over time (i.e., with various intracellular BUD concentrations). However, prolonged functional steroid activity is best attained when the cells are exposed to high concentrations of BUD so that substantial amounts of conjugates are formed. Thus, pulse incubation of transfected Rat1 cells with 10 Ϫ7 mol/liter BUD resulted in more prolonged activity than 10 Ϫ9 mol/liter BUD (data not shown). This concept is also supported by the BUD kinetics in situ in the rat trachea (5) . Here the most marked retention of BUD was obtained at the large airway level, where the BUD deposition is most prominent. BUD concentration can be estimated to be about 10 Ϫ7 mol/liter at that level, whereas in plasma the concentration is suggested to be around 10 Ϫ9 mol/liter (1). Presumably BUD, having a lower lipophilicity and thus higher water solubility than FP, can rapidly be taken up into the target tissue and there converted to the much more lipophilic fatty acid conjugates. Thus, the high BUD concentration at target can, by the reversible fatty acid conjugation mechanism, result in a local, marked prolongation of activity.
BUD-oleate was about 150 times less potent in downregulating TRE than BUD in this study. The minute GCS activity of BUD-oleate might even depend on a small contamination with BUD. Obviously, at extracellular addition to transfected Rat1 cells, the preformed conjugate did not have access to the intracellular enzymes, presumably lipases, that have been shown to hydrolyze the conjugate to active BUD (4, 27) . Its very limited water solubility might also contribute to the low activity in this in vitro study. Other studies have shown low receptor affinity of fatty acid conjugates of endogenous steroids (estrogens, androgens, or corticoids [28, 29] ) and synthetic GCS (data in files of Astra Draco and 2) coupled to low functional activity in vitro (29) .
The potency relationship between BUD and FP varied strongly whether the GCS were administered continuously or as a pulse. Under constant incubation FP was six times more potent, in agreement with earlier in vitro studies (19, 20) . On the other hand, after the pulse followed by washing, BUD was clearly more effective. The probable explanation for this shift is that FP is more easily and rapidly extracted from the cells than is the largely conjugated BUD. Thus, the extensive washing produced an approximately 50 times lower intracellular concentration of FP, which correlated to its much lower activity.
To investigate the deconjugation process further, CM experiments were performed. The CM produced by cells pretreated with 10 Ϫ7 mol/liter BUD mediated a greater downregulation than did CM from cells pretreated with 2 ϫ 10 Ϫ8 or 10 Ϫ7 mol/liter FP. This functional difference was explained by the GCS concentrations released into the CM. The estimated BUD concentration in CM was 10 times higher than for FP and sufficient to mediate a substantial downregulation of TRE. Of the total cellular amount of BUD before the CM production (comprising mainly conjugates), two-thirds were released, suggesting a marked deconjugation process over the 3-h period. Thus, a large enough intracellular depot of fatty acid esters of BUD can release active BUD to other cells as well as prolong GCS activity in the cell where it was first deposited. Supporting this concept, fatty acid esters of endogenous estrogens are known to prolong duration of activity in vivo (30, 31) , despite lacking receptor affinity (29, 32) .
In conclusion, this in vitro study shows that BUD is efficiently taken up and retained in transfected Rat1 cells, mainly in the form of fatty acid conjugates. This and related studies (4) (5) (6) demonstrated the reversibility of the conjugation process, releasing active BUD intra-and extracellularly. Pulse administration of BUD results in a more prolonged duration of GCS activity than after FP. This was demonstrated in cells treated directly and (using naive cells treated with CM) indirectly. The retention and activity of GCS in transfected Rat1 cells have been studied after pulse exposure plus extensive washing, intended to partly mimic the drainage occurring in the tissue by the blood circulation. It is pointed out that BUD and FP are inhaled in asthma as "pulses," normally once to twice a day, suggesting that, for duration studies, pulse administration is a more relevant administration mode in vitro than constant exposure. The concordance of our results in vitro with findings in the rat trachea in vivo (5, 6, 32) supports the use of such investigations in vitro for mechanistic aspects of the conjugation/deconjugation process.
